| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2001;38:803.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the University Department of Medicine (A.B., J. Ritchie, J. Rivera, T.M., K.C., L.B.), University of Western Australia; Western Australian Heart Research Institute Medicine, Royal Perth Hospital (A.B., J. Ritchie, J. Rivera, T.M., K.C., L.B.); and University Department of Obstetrics and Gynaecology (B.W., C.M.), King Edward Memorial Hospital, Perth, Western Australia.
Correspondence to Dr Anne Barden, University Department of Medicine, PO Box X2213, Perth, Western Australia 6847, Australia. E-mail abarden{at}cyllene.uwa.edu.au
Abstract Neutrophil activation occurs in women with preeclampsia and is resolved after delivery. The present study examined whether circulating factors in plasma of women with preeclampsia caused neutrophil activation and lipid peroxidation. Twenty-one women with proteinuric preeclampsia were matched for age and gestational age with 19 normal pregnant women. Plasma was collected from all subjects before delivery and at 6 weeks postpartum and incubated with autologous white-cell buffy coat collected at the postpartum visit. Neutrophil activation was assessed by level of CD11b and CD18 expression after incubation with autologous antepartum or postpartum plasma. Lipid peroxidation was assessed by measurement of F2-isoprostanes in plasma, plasmawhite cell incubates, and urine. Neutrophil CD11b and CD18 expression was not differentially altered by incubation with plasma from either women with preeclampsia or normal pregnant women and was similar between groups when incubation was performed with plasma collected after delivery. In preeclampsia, plasma F2-isoprostanes were significantly increased before and after delivery compared with controls. Plasma F2-isoprostanes were increased 2-fold after incubation of plasma with buffy coat, but preeclamptic women had higher levels compared with those of controls when either pregnant or postpartum plasma was used. In pregnant preeclamptics, plasma F2-isoprostanes were positively correlated with lymphocyte count. Six weeks after delivery, plasma F2-isoprostanes in the preeclamptic women were significantly positively associated with lymphocyte count and cholesterol and negatively associated with albumin. In conclusion, the present study does not suggest that a stable circulating factor causes neutrophil activation in preeclampsia. However, lipid peroxidation is elevated before and after delivery in women with preeclampsia, which suggests that these women may have an underlying predisposition to increased oxidative stress that may be driven by or contribute to a persistent low-grade inflammatory response.
Key Words: preeclampsia oxidative stress hypertension, gestational isoprostanes proteinuria inflammation pregnancy
This article has been cited by other articles:
![]() |
Md. Z. H. Howlader, S. Parveen, S. Tamanna, T. A. Khan, and F. Begum Oxidative Stress and Antioxidant Status in Neonates Born to Pre-eclamptic Mother J Trop Pediatr, April 20, 2009; (2009) fmp025v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood, C.-F. Yen, M. Basar, U. A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S. J. Huang, G. Krikun, and F. Schatz Preeclampsia-Related Inflammatory Cytokines Regulate Interleukin-6 Expression in Human Decidual Cells Am. J. Pathol., June 1, 2008; 172(6): 1571 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsukimori, H. Nakano, and N. Wake Difference in Neutrophil Superoxide Generation During Pregnancy Between Preeclampsia and Essential Hypertension Hypertension, June 1, 2007; 49(6): 1436 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O Scholl, M. Leskiw, X. Chen, M. Sims, and T P. Stein Oxidative stress, diet, and the etiology of preeclampsia Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1390 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Lee, P. A. Quinn, S. C. Jennings, and L. L. Ng NADPH Oxidase Activity in Preeclampsia With Immortalized Lymphoblasts Used as Models Hypertension, April 1, 2003; 41(4): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |